De Novo's Device Strategy Pays Off, Others May Follow
This article was originally published in Start Up
Executive Summary
De Novo Ventures, having successfully closed on its second fund, appears to be succeeding with a contrarian investment strategy that not only is dedicated to life sciences, but includes a strong commitment to medical devices.